Castle Biosciences (CSTL) Asset Utilization Ratio (2019 - 2026)

Castle Biosciences has disclosed Asset Utilization Ratio across 8 years of filings, most recently posting 0.6 for Q1 2026.

• Asset Utilization Ratio for Q1 2026 came in at 0.6, down 10.19% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.6 (down 10.19% YoY), and the FY2025 annual result was 0.62, down 8.03% from the prior year.
• Asset Utilization Ratio came in at 0.6 for Q1 2026 at Castle Biosciences, roughly flat from 0.6 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.67 in Q1 2025 to a low of 0.22 in Q1 2022.
• The 5-year median for Asset Utilization Ratio is 0.55 (2024), against an average of 0.49.
• Across the five-year window, Asset Utilization Ratio soared 65.04% in 2023 and dropped 10.19% in 2026, its largest moves.
• Castle Biosciences' Asset Utilization Ratio stood at 0.3 in 2022, then surged by 63.23% to 0.49 in 2023, then increased by 28.49% to 0.64 in 2024, then declined by 5.02% to 0.6 in 2025, then increased by 0.06% to 0.6 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.6 (Q1 2026), 0.6 (Q4 2025), and 0.62 (Q3 2025), per Business Quant data.